125 related articles for article (PubMed ID: 38937900)
1. Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial.
McNamara DM; Cooper LT; Arbel Y; Bhimaraj A; Bocchi E; Friedrich MG; Kerneis M; Liu P; Parker AB; Smith ER; Tang WHW; Torre-Amione G; Tschöpe C;
ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38937900
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
Makkar RR; Kereiakes DJ; Aguirre F; Kowalchuk G; Chakravarty T; Malliaras K; Francis GS; Povsic TJ; Schatz R; Traverse JH; Pogoda JM; Smith RR; Marbán L; Ascheim DD; Ostovaneh MR; Lima JAC; DeMaria A; Marbán E; Henry TD
Eur Heart J; 2020 Sep; 41(36):3451-3458. PubMed ID: 32749459
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis.
Kerneis M; Cohen F; Combes A; Amoura Z; Pare C; Brugier D; Puymirat E; Abtan J; Lattuca B; Dillinger JG; Hauguel-Moreau M; Silvain J; Salem JE; Gandjbakhch E; Hekimian G; Redheuil A; Vicaut E; Montalescot G;
Arch Cardiovasc Dis; 2023 Oct; 116(10):460-466. PubMed ID: 37640625
[TBL] [Abstract][Full Text] [Related]
9. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.
Armstrong PW; Roessig L; Patel MJ; Anstrom KJ; Butler J; Voors AA; Lam CSP; Ponikowski P; Temple T; Pieske B; Ezekowitz J; Hernandez AF; Koglin J; O'Connor CM
JACC Heart Fail; 2018 Feb; 6(2):96-104. PubMed ID: 29032136
[TBL] [Abstract][Full Text] [Related]
10. Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF.
Porcari A; Merlo M; Baggio C; Gagno G; Cittar M; Barbati G; Paldino A; Castrichini M; Vitrella G; Pagnan L; Cannatà A; Andreis A; Cecere A; Cipriani A; Raafs A; Bromage DI; Rosmini S; Scott P; Sado D; Di Bella G; Nucifora G; Marra MP; Heymans S; Imazio M; Sinagra G
Eur J Clin Invest; 2022 Oct; 52(10):e13815. PubMed ID: 35598175
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
12. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis.
Sanguineti F; Garot P; Mana M; O'h-Ici D; Hovasse T; Unterseeh T; Louvard Y; Troussier X; Morice MC; Garot J
J Cardiovasc Magn Reson; 2015 Aug; 17(1):78. PubMed ID: 26318624
[TBL] [Abstract][Full Text] [Related]
14. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA).
Pascual-Figal D; Núñez Villota J; Pérez-Martínez MT; González-Juanatey JR; Taibo-Urquía M; Llàcer Iborra P; González-Martín J; Villar S; Soler M; Mirabet S; Aimo A; Riquelme-Pérez A; Anguita Sánchez M; Martínez-Sellés M; Sánchez PL; Ibáñez B; Bayés-Genís A;
Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38837516
[TBL] [Abstract][Full Text] [Related]
15. [Predictive value of cardiac magnetic resonance-derived parameters on the improvement of left ventricular function in patients with acute viral myocarditis].
Ouyang HC; Ouyang FC; Mai LL; Chen YY; Hu YZ; Chen HX; Li WS
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):758-764. PubMed ID: 29036973
[No Abstract] [Full Text] [Related]
16. Intravenous immunoglobulin for presumed viral myocarditis in children and adults.
Robinson J; Hartling L; Vandermeer B; Sebastianski M; Klassen TP
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004370. PubMed ID: 32835416
[TBL] [Abstract][Full Text] [Related]
17. Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial.
Vaduganathan M; Claggett BL; Lam CSP; Pitt B; Senni M; Shah SJ; Voors AA; Zannad F; Desai AS; Jhund PS; Viswanathan P; Bomfim Wirtz A; Schloemer P; Lay-Flurrie J; McMurray JJV; Solomon SD
Eur J Heart Fail; 2024 Jun; 26(6):1324-1333. PubMed ID: 38742248
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double-blind, placebo-controlled trial.
Voors AA; Bax JJ; Hernandez AF; Wirtz AB; Pap AF; Ferreira AC; Senni M; van der Laan M; Butler J;
Eur J Heart Fail; 2019 Nov; 21(11):1426-1433. PubMed ID: 31523892
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.
Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
Eur Radiol; 2022 Nov; 32(11):7657-7667. PubMed ID: 35567603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
